Brain Diseases
Conditions
Keywords
MRI (magnetic resonance imaging), Neuroradiology, EPIMix (Echo planar imaging mix), Multicontrast EPI (echo planar imaging), Clinical validation
Brief summary
This study aims to assess the diagnostic feasibility and diagnostic performance of a new fast MR sequence EPIMix for neuroradiological evaluation in comparison to computed tomography of brain in pediatric population.
Detailed description
The study aims to assess the feasibility of fast MR sequence for neuroradiological evaluation in comparison to computed tomography of brain in pediatric population. Imaging quality is analysed with regards to artefacts and lesion conspicuity as well as its diagnostic potential in rendering a probable diagnosis. The primary study aim is to define feasibility and the AUC for diagnostic performance of minute MRI compared to computed tomography. Included patients are children age 4-18 with suspicion of cerebral pathology with referral to elective computed tomography of the brain. Study participants are in addition to computed tomography investigated during same day at 3T MR.
Interventions
DIAGNOSTIC_TESTMRI
Brain MRI without intravenous contrast
Sponsors
GE Healthcare
Karolinska University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Age 4-18 years. * Patient with suspicion of cerebral pathology. * Referral to elective brain CT study.
Exclusion criteria
* CT planned with sedation * known previous cerebral pathology (follow up study) * Emergency CT * Aborted MR exam
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Tolerance of a new fast MR method in children | At 0 hours | Number of aborted MR |
| Diagnostic potential | At 0 hours | Diagnostic accuracy to categorize scan as normal or abnormal on a five point Likert scale (1 - definitely normal, 2 - Probably normal, 3 - Indeterminate, 4 - Probably abnormal, 5 - Definitely abnormal) compared to abnormal/normal brain CT. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic imaging quality | At 0 hours | Diagnostic imaging quality (5 point Likert scale; 1 - Excellent diagnostic imaging quality, 2 - Good diagnostic imaging quality, 3 - Sufficient diagnostic imaging quality, 4 - Restricted diagnostic imaging quality, 5 - Poor diagnostic imaging quality) |
| Lesion description | At 0 hours | For example effect on brain parenchyma and size |
| Diagnostic confidence | At 0 hours | Five point Likert scale (Very confident, Predominantly confident, Fairly confident, Only slightly confident, Not at all confident) |
| Lesion classification | At 0 hours | Classification into disease categories (Neoplastic, Ischemic, Hemorrhagic, Infection, Neuroinflammation, Hydrocephalus, Congenital malformation, Indeterminate) |
| Ability to rule out diseases | At 0 hours | A list of diseases. Number of positive versus negative cases for each investigation (including: Tumor, Abscess, Parenchymal Haemorrhage, Acute Ischemia, Hydrocephalus, Neuroinflammation, Subarachnoid hemorrhage, Extraaxial fluid collection) |
| Artefacts | At 0 hours | Artefacts and impact (Motion, Beam hardening, Other) defined as; Not present, Not affecting diagnostic confidence, Degrading diagnostic confidence) |
| Clinical diagnostic summary report | At 0 hours | Text (one sentence summary of the finding including type of lesion and location) |
| Lesion location determination | At 0 hours | Anatomical localization of abnormality (Cerebrum, Cerebellum, Brainstem, Intraventricular, Subarachnoid space including basal cisterns, Intra-orbital, Skull/Skull base/dural, Other) |
Countries
Sweden
Outcome results
None listed